Full Text View
Tabular View
No Study Results Posted
Related Studies
Study Evaluating rhIL-11 in Active Crohn's Disease
This study has been completed.
Study NCT00040521   Information provided by Wyeth is now a wholly owned subsidiary of Pfizer

First Received on June 27, 2002.   Last Updated on February 7, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Crohn Disease
Inflammatory Bowel Disease
Additional conditions recognized in this trial
Inflammatory Bowel Diseases
Intestinal Diseases
More general conditions related to this trial
Digestive System Diseases
Gastroenteritis
Gastrointestinal Diseases
Additional drug interventions recognized in this trial
Oprelvekin
More general drug interventions related to this trial
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Wyeth is now a wholly owned subsidiary of Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services